Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
about
Postviral fatigue syndrome: time for a new approachHigh levels of type 2 cytokine-producing cells in chronic fatigue syndromeMarkers of viral infection in monozygotic twins discordant for chronic fatigue syndromeImmunologic abnormalities in chronic fatigue syndromeThe pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures.Neuroaetiology of chronic fatigue syndrome: an overview.Absence of parvovirus B19 infection in chronic fatigue syndrome.Sensory and cognitive event-related potentials in myalgic encephalomyelitis.Chronic fatigue syndrome. A critical appraisal of the role of Epstein-Barr virusMuscle strength, endurance and recovery in the post-infection fatigue syndromeSevere chronic active EBV infection in an adult patient: case report.Chronic fatigue syndrome: new insights and old ignorance.Borna disease virus infection in two family clusters of patients with chronic fatigue syndrome.Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.EBV Chronic InfectionsRecovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review.Longitudinal study of outcome of chronic fatigue syndrome.High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness.alpha-Interferon treatment of patients with chronic fatigue syndrome.Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community.Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infectionRandomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.Chronic Epstein-Barr virus syndrome.Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infectionAntibody to Coxsackie B virus in diagnosing postviral fatigue syndrome.Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.The chronic fatigue syndrome.A review and meta-synthesis of qualitative studies on myalgic encephalomyelitis/chronic fatigue syndrome.Human herpesvirus 6 and chronic fatigue syndromeProposed guidelines for diagnosing chronic active Epstein-Barr virus infection.Pathologic effects of RNase-L dysregulation in immunity and proliferative control.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Chronic mononucleosis syndromeEpstein-Barr virus and human diseases: recent advances in diagnosisSevere chronic active Epstein-Barr virus infection syndromeChronic fatigue syndrome. A fresh look at an old problem.
P2860
Q24647114-F46F1A08-C48C-4A48-B39D-D65AFFDA33ACQ24684394-005C0B27-03BD-411F-BE75-A264B4685870Q28217481-A2317551-D51B-4D7A-9057-17D9E981A15DQ28240155-F4FC5693-AA76-4E49-B050-66D367F5CC65Q30834887-B6570585-B9E9-403B-848A-6C4E24967641Q31127930-5912C20C-39C5-47E1-9A00-FF18DD473F07Q33489675-0436E61E-3C21-4AEB-85AA-2F76744BB4C0Q33588751-69689302-12B7-4D53-B8EE-9F8BF4E39D84Q33616953-D915FD70-5D7B-43E7-BC53-D5789EED4B43Q33630768-128F3837-2EDC-4CD7-BDA9-4C0732B2225AQ33631625-444423D5-28B8-431B-BC27-A02E51790157Q33785889-F10DBD17-D913-4E31-9D52-715AA3372A50Q33877700-00EE94DF-53F2-4647-A103-5BD1F7B78947Q33973913-BBB8AF05-76AF-4784-8376-53AFFBB4971CQ34171625-2E5A9599-2B7B-48C7-A61E-B4B3100C94EAQ34228883-6AD02FE9-4C48-45F7-A1C9-E72280549844Q34338302-B3E920EC-6302-424B-B804-E73854C8AA3AQ34349689-D4CCBC32-9AD5-4F81-BEE7-BBEBDCCC92E1Q34386229-02C9BE70-FA8D-4F55-91FD-8C9E74057961Q34454963-9AE42D07-39EB-4036-AD76-6E3D92D8F7D4Q34472035-6C5E445F-41B1-438A-B3A7-AF5B57C1F910Q34513108-EAA7BD1F-279A-4E7B-B6A4-4FFA7C7AAE1AQ34568578-820F8BA4-22EC-4694-A702-23DB32E9A94DQ34590358-E44FA625-04F7-4F0E-935F-D2F985791D4FQ34655467-5228B534-7C31-4B04-832B-9FBF68714D80Q34742540-13B95253-95AE-4CC6-BF6C-05646AD7F704Q35121466-9488C3C6-405C-413F-833E-AEF1FB07629DQ35160206-E1A205B4-75C9-41F9-BB9F-2D14B33A046CQ35178232-6DCD502C-1997-43F6-8BF1-A15BBE23D1DAQ35235144-6E9938D5-CE92-4BA6-AC71-6294E4CD1B4FQ35536852-8279704E-3A67-42CA-AAFE-617DA6780DF9Q35589565-9FB82B37-2184-421B-90AE-F00165FB707DQ35649869-A5C92331-FB74-44E4-ABF8-F38AAB3CBF7EQ36247163-E748615D-8401-4AC0-8D9F-7518B946F652Q36310770-452A4B1B-6350-4718-967F-7C8A0D43ACBEQ36399124-60E50CC7-D97E-41E1-9527-A83158B37C0DQ36576724-D77C129D-8820-4425-98B0-1C587EAF2999Q36633160-F96A163D-03F4-4F81-922C-76962E328F6CQ36636997-223C29ED-3889-4DB1-B2FA-C3B863D86157Q36652551-1D501373-C5ED-4E63-B851-A5CC6DE62E25
P2860
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@ast
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@en
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@nl
type
label
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@ast
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@en
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@nl
prefLabel
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@ast
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@en
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@nl
P2093
P1476
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.
@en
P2093
Armstrong G
P356
10.7326/0003-4819-102-1-7
P407
P577
1985-01-01T00:00:00Z